Startups.Bio showcases an emerging biotech startup each week, selected by the analyst team at VentureRadar from the 10,000s of companies we track.
Eradivir has developed a small molecule technology that tethers immune cells to diseased cells, with the potential to treat multiple viral diseases and cancers. Eradivir “MiniBITs” are small bispecific molecules that engage both a cytotoxic immune cell and a virus/virus-infected or cancer cell. Upon bridging between the two cell types, the immune cell is activated […]
Protai has built an AI-based platform that maps the course of diseases on the protein level, enhancing the ability to observe cellular function and discover new drugs. By systematically mapping diseases on the protein level the company aims to create an entirely new layer of functional information that enables identification of therapeutic and diagnostic targets. […]
NonExomics is focused on the non-exome regions of the genome and has identified hundreds of potential new drug targets across rare diseases, neuropsychiatric disorders, and cancer. The parts of our DNA that code for proteins make up around 2% of the human genome and are collectively known as the exome. The exome is the best […]